ClearColi as a platform for untagged pneumococcal surface protein A production: cultivation strategy, bioreactor culture, and purification

ABSTRACT: Several studies have searched for new antigens to produce pneumococcal vaccines that are more effective and could provide broader coverage, given the great number of serotypes causing pneumococcal diseases. One of the promising subunit vaccine candidates is untagged recombinant pneumococca...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Valdemir M., Paredes, Sheyla A. H., Campani, Gilson, Gonçalves, Viviane M., Zangirolami, Teresa C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Biotechnological Products and Process Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755982/
https://www.ncbi.nlm.nih.gov/pubmed/35024919
http://dx.doi.org/10.1007/s00253-022-11758-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755982/
https://www.ncbi.nlm.nih.gov/pubmed/35024919
http://dx.doi.org/10.1007/s00253-022-11758-9

Ejemplares similares